In this study, we demonstrated that BTS mitigated depression-like behaviors in HFD-induced obese mice, mediated in part through the regulation of systemic/neuroinflammation, BDNF signaling, hippocampal NMDARs, and intrasynaptic 5-HT levels. Here, BDNF is linked to depressive symptom measurement.